Use of mglur5 antagonists for the treatment of pruritic conditions
OwnerFabrizio Gasparini, Laszlo Urban +1inventors
InventorsFabrizio Gasparini, Laszlo Urban, Josef Gottfried Meingassner
Life of this patent
Estimating the term…
Abstract
The invention provides the use of mGluR5 receptor antagonists for the treatment of pruritic conditions.
Claims7
The use of an mGluR5 antagonist for the treatment of pruritic conditions.
The use of a mGluR5 antagonist in the manufacture of a pharmaceutical composition for the treatment of pruritic conditions.
A pharmaceutical composition incorporating as active agent a mGluR5 antagonist for use in the treatment of pruritic conditions.
A method of treating pruritic conditions in a subject in need of such treatment, comprising administration to such subject of a therapeutically effective amount of a mGluR5 antagonist.
Dependencies are inferred from the claim text.